Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

296 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

NCT05846789

Conditions
Breast Diseases, Breast Neoplasms, ER Positive, HER2 Negative Breast Cancer, +8 more
Locations
  • Emory University Atlanta, Georgia, United States
  • IU Health Joe and Shelly Schwarz Cancer Center Carmel, Indiana, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions